| OMNICELL INC. DL-,001 |
| USA |
| Gesundheit |
| US68213N1090 / 632313 |
| OC9 (Frankfurt) / OMCL (NASDAQ) |
| FRA:OC9, ETR:OC9, OC9:GR, NASDAQ:OMCL |
| - |
| https://www.omnicell.com/ |
|
Omnicell Inc. operates as a provider of medication management solutions and adherence tools within the healthcare industry. Its primary function is to optimize medication management and supply chain processes in healthcare facilities, aiming to enhan..
>Volltext.. |
| 1327.23 Mio. EUR |
| 1287.94 Mio. EUR |
| 1014.67 Mio. EUR |
| 79.46 Mio. EUR |
| 1.76 Mio. EUR |
| 0.04 EUR |
| 175 Mio. EUR |
| 214.98 Mio. EUR |
| 109.02 Mio. EUR |
| 0.53 |
| -6.11% |
| -85.57% |
| - |
| - |
| - |
| OMNICELL |
| 09.04.26 |
|